A detailed history of Nvest Financial, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nvest Financial, LLC holds 499 shares of VRTX stock, worth $231,815. This represents 0.14% of its overall portfolio holdings.

Number of Shares
499
Previous 499 -0.0%
Holding current value
$231,815
Previous $233,000 0.43%
% of portfolio
0.14%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$392.81 - $485.53 $1,178 - $1,456
-3 Reduced 0.6%
499 $233,000
Q1 2024

Apr 18, 2024

SELL
$407.69 - $446.08 $2,446 - $2,676
-6 Reduced 1.18%
502 $209,000
Q4 2023

Jan 22, 2024

BUY
$343.0 - $410.68 $174,244 - $208,625
508 New
508 $206,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nvest Financial, LLC Portfolio

Follow Nvest Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvest Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvest Financial, LLC with notifications on news.